Life stage

Reproductive years

From menarche through the premenopausal adult years, including menstrual-cycle variation and contraception considerations.

Leuprolide has established use in endometriosis and uterine fibroids during reproductive years. Oxytocin is used for labor induction. GLP-1 and dual incretin agonists are approved for metabolic conditions but should be stopped before pregnancy; contraception and menstrual-cycle effects are underreported.

Relevant approved medicines and indications

Leuprolide

GnRH agonist

Oxytocin

Posterior pituitary hormone / peptide

Evidence gaps and exclusion patterns

Contraceptive interaction data
Menstrual-cycle effects

Recent audits and articles

Were women studied? Leuprolide endometriosis clinical development program

Leuprolide endometriosis trials enrolled women with the condition, but comparative sex analyses are not relevant by design.

Questions for clinician conversations

What evidence exists for people in my life stage?
What are the known unknowns for this medicine in this population?
How should I monitor for adverse effects?

Author

Ian Gauntt

RN, BSN — 10 years as a critical care nurse

Medical reviewer

Medical Reviewer (Pending Assignment)

Medical review pending assignment by a licensed clinician.

Last reviewed 2026-08-01Next review 2026-11-01

Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.